Back
Lifevantage 10K Form
Buy
83
LFVN
Lifevantage
Last Price:
16.00
Seasonality Move:
28.76%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-02 | 10Q | LFVN/Lifevantage Quarterly |
2024-01-30 | 10Q | LFVN/Lifevantage Quarterly |
2023-11-09 | 10Q | LFVN/Lifevantage Quarterly |
2023-05-04 | 10Q | LFVN/Lifevantage Quarterly |
2023-02-02 | 10Q | LFVN/Lifevantage Quarterly |
2022-11-02 | 10Q | LFVN/Lifevantage Quarterly |
Receive LFVN News And Ratings
See the #1 stock for the next 7 days that we like better than LFVN
LFVN Financial Statistics
Sales & Book Value
Annual Sales: | $200.16M |
---|---|
Cash Flow: | $-932K |
Price / Cash Flow: | 35.97 |
Annual Sales: | $2.22 |
Price / Book: | 6.83 |
Profitability
EPS (TTM): | 0.32000 |
---|---|
Net Income (TTM): | $4.13M |
Gross Margin: | $158.72M |
Return on Equity: | 15.08% |
Return on Assets: | 6.62% |
Lifevantage Earnings Forecast
Key Lifevantage Financial Ratios
- The Gross Profit Margin over the past 26 years for LFVN is 79.30%.
- The Selling, General & Administrative Expenses for LFVN have been equal to 77.13% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 0.32% of Operating Income.
- The Net Earning history of LFVN is 1.47% of Total Revenues.
- Per Share Earnings over the last 28 years have been positive in 12 years.
Lifevantage Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Personal Care Products |
Sector: | Consumer Staples |
Current Symbol: | LFVN |
CUSIP: | 53222K |
Website: | lifevantage.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 1.76 |
Quick Ratio: | 0.84 |
Price-to-Earnings
Trailing P/E Ratio: | 65.65 |
---|---|
Forward P/E Ratio: | 18.19 |
LFVN Technical Analysis vs Fundamental Analysis
Buy
83
Lifevantage (LFVN)
is a Buy
Is Lifevantage a Buy or a Sell?
-
Lifevantage stock is rated a Buy
The current Lifevantage [LFVN] share price is $16.04. The Score for LFVN is 83, which is 66% above its historic median score of 50, and infers lower risk than normal.